Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunohistochemistry Arginase1 Test

The Immunohistochemistry Arginase1 Test helps diagnose and manage cancer by assessing Arginase1 enzyme levels in tumor tissue. This test provides valuable information for oncologists to guide treatment decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block.
Results
5-7 days. Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Ensure to ship at room temperature and provide a copy of the Histopathology report, site of biopsy, and clinical history.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Arginase1 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Diagnosis of certain cancers
  • ✓Prognosis assessment in specific cancers
  • ✓Guiding treatment decisions
  • ✓Monitoring treatment response
  • ✓Research purposes
02

In plain language

What this test helps you understand

Provides information on Arginase1 expression in tumor tissue, aiding in cancer diagnosis and treatment planning.
The Immunohistochemistry Arginase1 Test is a diagnostic tool used in oncology to understand tumor biology. It detects the presence and level of the Arginase1 enzyme within tumor tissue samples. This enzyme is associated with certain types of cancer, and its expression can provide important clues for diagnosis and treatment planning.

This test measures the amount of Arginase1 protein expressed by the tumor cells. Understanding these levels can help healthcare providers make more informed decisions about patient care.

Patients who may benefit from this test include those suspected of having cancer, those already diagnosed, or those undergoing treatment evaluation. It can be particularly useful for understanding specific tumor characteristics and guiding personalized treatment strategies.

Results from the test are typically available within 5-7 days. Your doctor will interpret these results alongside your medical history and other diagnostic findings to determine the best course of action.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Ensure to ship at room temperature and provide a copy of the Histopathology report, site of biopsy, and clinical history.
SampleTumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block.
MethodologyImmunohistochemistry (IHC)
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects Arginase1 expression but does not provide a definitive cancer diagnosis on its own. Results must be interpreted by a qualified healthcare professional in conjunction with other clinical information.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Arginase1 is an enzyme that can be found in certain types of cancer cells. This test measures its presence and level in tumor tissue.
Understanding Arginase1 levels can help doctors diagnose cancer, predict its behavior, and choose the most effective treatment.
A sample of tumor tissue, usually obtained from a biopsy or surgery, is required for this test.
Results are typically available within 5-7 days, but confirm with the laboratory before booking.
A qualified pathologist or oncologist will interpret the results in the context of your overall health and medical history.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp